SpyGlass Pharma Inc
NASDAQ:SGP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
SpyGlass Pharma Inc
NASDAQ:SGP
|
US |
|
R E A Holdings PLC
LSE:RE
|
UK |
SpyGlass Pharma Inc
SpyGlass Pharma develops eye-treatment products that are designed to deliver medicine inside the eye over a long period of time. Its core idea is to replace frequent eye drops with a small implant or drug-delivery device that an ophthalmologist can place during a routine eye procedure, especially for people being treated for glaucoma or eye pressure control. The company’s customers are eye doctors, ambulatory surgery centers, and hospitals that perform these procedures, with the end users being patients who need ongoing treatment for chronic eye disease. SpyGlass Pharma would make money by selling its device or implant, and possibly related procedure-specific products, to the medical providers who use it. What makes the business different is that it sits between traditional drug makers and medical device companies. Instead of selling a pill or bottle of drops, it packages medicine into an implanted delivery system, which can make treatment more convenient for patients and more consistent for doctors.
SpyGlass Pharma develops eye-treatment products that are designed to deliver medicine inside the eye over a long period of time. Its core idea is to replace frequent eye drops with a small implant or drug-delivery device that an ophthalmologist can place during a routine eye procedure, especially for people being treated for glaucoma or eye pressure control.
The company’s customers are eye doctors, ambulatory surgery centers, and hospitals that perform these procedures, with the end users being patients who need ongoing treatment for chronic eye disease. SpyGlass Pharma would make money by selling its device or implant, and possibly related procedure-specific products, to the medical providers who use it.
What makes the business different is that it sits between traditional drug makers and medical device companies. Instead of selling a pill or bottle of drops, it packages medicine into an implanted delivery system, which can make treatment more convenient for patients and more consistent for doctors.
